Alpha-Linolenic Acid Levels Inversely Linked to Risk of Death in ALS
TUESDAY, June 27, 2023 -- Higher plasma levels of the polyunsaturated fatty acid (PUFA) alpha-linolenic acid (ALA) is associated with reduced risk of death in patients with amyotrophic lateral sclerosis (ALS), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2023 Category: Pharmaceuticals Source Type: news
Cognitive impairment is associated with gait variability and fall risk in amyotrophic lateral sclerosis - Dubbioso R, Spisto M, Hausdorff JM, Aceto G, Iuzzolino VV, Senerchia G, De Marco S, Marcuccio L, Femiano C, Iodice R, Salvatore E, Santangelo G, Trojano L, Moretta P.
BACKGROUND: In amyotrophic lateral sclerosis (ALS), gait abnormalities contribute to poor mobility and represent a relevant risk for falls. To date, gait studies in ALS patients focused on the motor dimension of the disease, underestimating the cognitive a... (Source: SafetyLit)
Source: SafetyLit - June 24, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Omega-3 Fatty Acids Tied to Slower ALS Progression
(MedPage Today) -- Plasma levels of omega-3 fatty acids, especially alpha-linolenic acid (ALA), were tied to slower disease progression in people with amyotrophic lateral sclerosis (ALS), observational data showed.
Over an 18-month study period... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - June 22, 2023 Category: Neurology Source Type: news
Omega-3 Fatty Acids Linked to Slowed ALS Progression Omega-3 Fatty Acids Linked to Slowed ALS Progression
Certain polyunsaturated fatty acids (PUFAs) may have a favorable effect on disease progression and survival for patients with amyotrophic lateral sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 22, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Diet Heavy in Omega-3s Might Help Slow ALS
THURSDAY, June 22, 2023 -- Consuming omega-3 fatty acids like flaxseed oil and walnuts may help slow the decline in physical function related to amyotrophic lateral sclerosis (ALS), new research suggests.
ALS (formerly known as Lou Gehrig ' s disease)... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2023 Category: General Medicine Source Type: news
ALS: Why this neurodegenerative disease needs 'rare' tag
Experts and medical practitioners have demanded the inclusion of the progressive neurodegenerative disease - Amyotrophic lateral sclerosis (ALS) - in the national rare disease policy to enable patients to get affordable care and treatment. The demand came ahead of the Global ALS/MND (motor neurone disease) Awareness Day, was observed on Wednesday. (Source: The Economic Times)
Source: The Economic Times - June 22, 2023 Category: Consumer Health News Source Type: news
Can a Repurposed Parkinson's Drug Slow ALS Progression? Can a Repurposed Parkinson's Drug Slow ALS Progression?
Ropinirole, a Parkinson ' s disease drug, shows promise in slowing the progression of amyotrophic lateral sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 21, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Sports-related concussions not proved to cause later brain disease, says expert group
An expert committee of clinicians and researchers today called for an end to most types of bodychecking, a collision tactic, in youth ice hockey, and backed other changes for preventing and treating sports-related concussions. But the international panel offered no resolution to an especially controversial question in professional sports—the extent to which repetitive head injuries cause brain disease later in life—instead saying rigorous cohort studies are needed to prove a causal relationship.
“We need … much better designed case control and cohort studies that include most importantly, careful control of t...
Source: ScienceNOW - June 14, 2023 Category: Science Source Type: news
Physical Activity as an Exogenous Risk Factor for ALS Physical Activity as an Exogenous Risk Factor for ALS
Has strenuous physical activity been established as an additional risk factor for amyotrophic lateral sclerosis? A new review looks at the current evidence.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 6, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Apple created its new voice feature for —and with
To help those living with ALS digitize their unique voices, Apple leveraged cutting-edge AI—and did a lot of listening. Among the many challenges people living with amyotrophic lateral sclerosis (ALS) face is its impact on their speech. By weakening muscles in the throat and mouth, the progressive…#als #apple #readfullstory (Source: Reuters: Health)
Source: Reuters: Health - May 18, 2023 Category: Consumer Health News Source Type: news
The Broader Significance of a New Drug for a Rare Form of ALS
(MedPage Today) -- A major milestone in the treatment of amyotrophic lateral sclerosis (ALS) occurred on April 25, 2023, when the FDA approved tofersen (Qalsody) for patients carrying the disease-causing mutation superoxide dismutase 1 (SOD1)... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 15, 2023 Category: American Health Source Type: news
New UAB clinic for amyotrophic lateral sclerosis opens
ALS is a rare neurological disease that affects motor neurons. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 10, 2023 Category: Pharmaceuticals Authors: Laurel Thrailkill Source Type: news
Drug for Rare Form of Lou Gehrig's Disease OK'd by FDA
It's the first drug for an inherited form of ALS, or amyotrophic lateral sclerosis, a deadly disease that destroys nerve cells needed for basic functions like walking, talking and swallowing. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - April 26, 2023 Category: American Health Source Type: news
Qalsody Targets Mutation in Rare, Inherited ALS
WEDNESDAY, April 26, 2023 -- The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS). The medication, Qalsody (tofersen), targets a mutation in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2023 Category: General Medicine Source Type: news
Confirmed: Mast Cell Drug Curbs ALS Mortality
(MedPage Today) -- BOSTON -- When phase II/III trial results were published in 2019 for a novel approach to treating amyotrophic lateral sclerosis (ALS), the 48-week data left an important question unanswered: did the treatment extend survival... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - April 26, 2023 Category: Neurology Source Type: news
